In TRA-2P Study, adding Merck’s vorapaxar to standard of care significantly reduced the risk of cardiovascular events
24 March 2012 | By Merck
Results from TRA-2P study - published...
List view / Grid view
News
GSK and Theravance announce completion of the Relovair™* registrational programme
23 March 2012 | By GlaxoSmithKline
COPD and asthma regulatory plans remain on track for submission from mid-2012...
BYETTA® approved for use with basal insulin in Europe
23 March 2012 | By Amylin Pharmaceuticals, Inc.
Patients in pivotal study achieved better glycemic control overall and after meals...
Catalent extends development and analytical solutions capabilities in Swindon, UK
22 March 2012 | By Catalent Pharma Solutions
Catalent Pharma Solutions announces the completion of new Development and Analytical Solutions’ laboratories at its facility in Swindon, UK.
UK court finds SEROQUEL XR® formulation patent invalid
22 March 2012 | By AstraZeneca
The High Court in the UK has rendered its opinion on the formulation patent protecting SEROQUEL XR®...
GSK confirms significant investments in UK manufacturing: Ulverston in Cumbria selected as site of new biopharmaceutical factory
22 March 2012 | By GlaxoSmithKline
Up to 1,000 new jobs created...
Lundbeck appoints new vice president of business development
21 March 2012 | By Lundbeck
Lundbeck has appointed Jacob Tolstrup as new vice president with responsibility for the company's business development...
Abbott selects AbbVie as new name for future research-based pharmaceutical company
21 March 2012 | By Abbott
AbbVie the new, independent research-based pharmaceutical company...
Interview with Susan Najjar, Marketing Director for Informatics at Thermo Fisher Scientific
Freddy White, European Pharmaceutical Review speaks to Marketing Director for Informatics at Thermo Fisher Scientific, Susan Najjar...
Update on FDA Advisory Committee vote on investigational medicine Ridaforolimus
20 March 2012 | By Merck
"Merck remains confident in the potential of the investigational agent ridaforolimus..."
GSK announces positive vote from FDA panel for pazopanib in certain advanced soft tissue sarcomas
20 March 2012 | By GlaxoSmithKline
“Treatment options for patients with advanced soft tissue sarcoma are limited..."
Abbott reinforces global vascular leadership with new data on innovative technologies at ACC 2012
20 March 2012 | By Abbott
Abbott announced the company's schedule of key presentations...
Remaining TC-5214 Phase III efficacy studies do not meet endpoint, regulatory filing will not be pursued
20 March 2012 | By AstraZeneca
Top-line results from the remaining Phase III studies - announced...
Merck and Safe Water Network launch Initiative
20 March 2012 | By Merck
Collaboration advances Merck's commitment to fighting disease to help the world be well...
Pradaxa® (dabigatran etexilate) receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK
19 March 2012 | By NICE
Pradaxa® must now be made available for use by the UK National Health Service (NHS)...
